Dr Rachel Speer brings to ECIR a range of scientific and medical communications experience, spanning continuing medical education, medical affairs, promotional medical education, sales training, and scientific marketing. Her therapeutic area expertise includes chronic kidney disease, multiple sclerosis, migraine, Parkinson disease, Huntington disease, tardive dyskinesia, Alzheimer disease, amyotrophic lateral sclerosis, asthma, chronic obstructive pulmonary disease, nasal polyps, and other areas within neurology, cardio-renal-metabolic disease, and women’s health.
Dr Speer joined ECIR in 2021 with 8 years of professional experience in scientific/medical communications and education following completion of her doctoral training in neuroscience at the Weill Cornell Graduate School of Medical Sciences. Prior to graduate school, she held a 2-year postbaccalaureate research fellowship at the National Institutes of Health and received a bachelor degree cum laude from Amherst College, with majors in biology and history.
Over the course of her career, Dr Speer has gained experience leading commercial, medical affairs, and clinical research-related initiatives across all stages of a product life cycle, including strategic advisory boards, key opinion leader engagement, scientific platform development, competitive intelligence analysis, disease state and branded asset development (eg, slide deck presentations, patient cases, videos), speakers’ bureau content development and training, medical science liaison training and external presentations, congress support, publications, and other customized deliverables and consultative services that meet clients’ diverse needs. She is passionate about collaboration and lifelong learning as key means to executing high-impact initiatives that will improve patient outcomes.